Analytics
BioVal™ analysis: Alzinova’ ALZ-101 valued at SEK 7.1B
BioVal
Hansa closes, AlzeCure soars, Ascelia falters – the Nordic Pulse | 2026:27
Analytics
State of Nordic Biopharma | Q2 2026
Analytics
BioVal™ analysis: Elicera Therapeutics’ ELC-301 valued at SEK 631M
BioVal
BioArctic lands Lilly, Sobi takes a late hit – the Nordic Pulse | 2026:26
Alvotech cashes up, SynAct narrowly misses – the Nordic Pulse | 2026:25
Lilly calls on AlzeCure, Novo Nordisk pops a pill – the Nordic Pulse | 2026:24
Lundbeck breaks through, Sectra breaks records – The Nordic Pulse | 2026:23
Hansa shines, Elekta stumbles, biotech bounces – the Nordic Pulse | 2026:22
Deals, Data and a Dragon Market Debut – the Nordic Pulse | 2026:21
Consensus Analysis | Novo Nordisk | 19 May 2026
